Routine antenatal care & screening schedule
ANC · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Structured programme of visits, investigations and screening across pregnancy to optimise maternal and fetal outcomes and identify risk early. Nulliparous women are offered around 10 contacts and parous women around 7.
Red flags
- Reduced fetal movements
- Severe headache with visual disturbance or epigastric pain
- Vaginal bleeding or fluid loss
- Persistent reduced symphysis-fundal height or static growth
- Disclosure of domestic abuse or suicidal ideation
Assessment
Differential diagnosis
- Uncertain dating
- Undisclosed pre-existing medical disease
- Unrecognised high-risk pregnancy
- Occult multiple pregnancy
- Early-onset pre-eclampsia risk
Investigations
- Booking bloods: FBC, blood group & antibodies, haemoglobinopathy screen, HIV/hepatitis B/syphilis
- Dating ultrasound 11+2 to 14+1 weeks with combined Down screening (nuchal translucency, PAPP-A, beta-hCG)
- Mid-trimester anomaly scan 18+0 to 20+6 weeks
- Urine culture for asymptomatic bacteriuria, urinalysis for protein
- GTT if risk factors, repeat FBC/antibodies at 28 weeks
- BP and symphysis-fundal height at each contact from 24 weeks
Management
- Confirm pregnancy and arrange booking appointment ideally before 10 weeks
- Take full history including medical, obstetric, mental health, FGM and domestic abuse screening
- Calculate EDD from LMP then confirm by crown-rump length at dating scan
- Risk-assess for pre-eclampsia, VTE, gestational diabetes and fetal growth restriction and start aspirin/LMWH as indicated
- Offer and document first and second trimester screening with informed consent
- Prescribe folic acid 400 micrograms (5 mg if high risk) and vitamin D 10 micrograms daily
- Check and offer immunisations: pertussis from 16 weeks, influenza and RSV vaccine in season
- Give anti-D prophylaxis to RhD-negative women at 28 weeks
- Measure symphysis-fundal height serially and plot on customised chart
- Discuss birth preferences, screen for mental health at every contact, and plan postnatal care
Drugs & doses
Folic acid 400 micrograms PO once daily preconception to 12 weeks
Vitamin D (cholecalciferol) 10 micrograms (400 units) PO once daily
Pertussis-containing vaccine (dTaP/IPV) 0.5 mL IM from 16 weeks
Anti-D immunoglobulin 1500 units IM at 28 weeks if RhD negative
Disposition
Community midwifery-led care for low-risk; refer to obstetric-led clinic for any identified risk factor, and to maternal medicine or fetal medicine for specific conditions.
Complications & pitfalls
- Missed window for aneuploidy screening
- Undetected fetal growth restriction
- Late booking limiting intervention
- Unidentified maternal anaemia or infection
- Failure to recognise mental health deterioration
Exam pearls
- Date by scan rather than LMP whenever they differ by more than 5-7 days
- A single raised BP at booking warrants repeat and risk stratification, not dismissal
- Customised growth charts improve detection of small-for-gestational-age fetuses
- Document consent and declined tests clearly
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.